AMENDMENT NO. 4 TO STRATEGIC SUPPLIER ALLIANCE AGREEMENTStrategic Supplier Alliance Agreement • May 8th, 2018 • Repligen Corp • Biological products, (no disgnostic substances)
This Amendment No. 4 (the “Fourth Amendment”) to the certain Strategic Supplier Alliance Agreement dated as of July 7, 2011 (the “Supplier Agreement”) by and between Repligen Sweden AB, formerly known as Novozymes Biopharma AB, (the “Supplier”) a company organized under the laws of Sweden and a wholly owned subsidiary of Repligen Corporation (“Repligen”) and GE Healthcare Bio-Sciences AB, a company organized under the laws of Sweden (“GEHC”) is made effective as of the date of last signature (the “Amendment Effective Date”) with reference to the following:
AMENDMENT NO. 1 TO STRATEGIC SUPPLIER ALLIANCE AGREEMENTStrategic Supplier Alliance Agreement • March 15th, 2012 • Repligen Corp • Biological products, (no disgnostic substances) • New York
THIS AMENDMENT NO. 1 (the “Amendment”) to that certain Strategic Supplier Alliance Agreement dated as of January 28, 2010 (the “Supplier Agreement”), by and between Repligen Corporation, a Delaware corporation (“Supplier”), and GE Healthcare Bio-Sciences AB, a company organized under the laws of Sweden (“GEHC”), is entered into on October 27, 2011, by and between Supplier and GEHC.
